KRYSTAL BIOTECH INC (KRYS)
US5011471027 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 10.93M | -139.98M | -69.57M | -32.17M | -19.09M | |||
| Depreciation Amortization | 5.01M | 4.06M | 2.77M | 1.85M | 1.09M | |||
| Change In Working Capital | -137.88M | 2.81M | 2.05M | 930.00K | -2.00M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 33.14M | 32.54M | 16.81M | 3.31M | 1.31M | |||
| OPERATING CASH FLOW | -88.80M | -100.57M | -47.94M | -26.08M | -18.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.80M | -52.98M | -68.34M | -14.84M | -6.40M | |||
| Other Investing Activity | 94.44M | -61.10M | -158.43M | 3.66M | 1.41M | |||
| INVESTING CASH FLOW | 82.64M | -114.08M | -226.77M | -11.18M | -4.99M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 203.50M | 36.00M | 355.65M | 118.02M | 107.53M | |||
| Other Financing Activity | -749.00K | -650.00K | -7.96M | N/A | N/A | |||
| FINANCING CASH FLOW | 202.75M | 35.35M | 347.69M | 118.02M | 107.53M | |||
| Exchange Rate Effect | -156.00K | -40.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | 196.43M | -179.34M | 72.98M | 80.76M | 83.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -88.80M | -100.57M | -47.94M | -26.08M | -18.69M | |||
| Capital Expenditure | -11.80M | -52.98M | -68.34M | -14.84M | -6.40M | |||
| FREE CASH FLOW | -100.60M | -153.55M | -116.28M | -40.92M | -25.09M | |||
All data in USD